APA (7th ed.) Citation

Meng, J., Qian, W., Yang, Z., Gong, L., Xu, D., Huang, H., . . . Zou, J. (2024). p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme. BMC cancer, 24(1), 317-13. https://doi.org/10.1186/s12885-024-12017-y

Chicago Style (17th ed.) Citation

Meng, Jiao, et al. "P53/E2F7 Axis Promotes Temozolomide Chemoresistance in Glioblastoma Multiforme." BMC Cancer 24, no. 1 (2024): 317-13. https://doi.org/10.1186/s12885-024-12017-y.

MLA (9th ed.) Citation

Meng, Jiao, et al. "P53/E2F7 Axis Promotes Temozolomide Chemoresistance in Glioblastoma Multiforme." BMC Cancer, vol. 24, no. 1, 2024, pp. 317-13, https://doi.org/10.1186/s12885-024-12017-y.